You have 9 free searches left this month | for more free features.

Chemotherapy

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Carcinomatosis Trial (Cytoreductive surgery combined with HIPEC, bevacizumab and HIPEC (Oxaliplatin 360 mg/m2).)

Withdrawn
  • Colorectal Carcinomatosis
  • Cytoreductive surgery combined with HIPEC
  • bevacizumab and HIPEC (Oxaliplatin 360 mg/m2).
  • (no location specified)
Nov 13, 2018

Therapeutic Care in Metastatic Breast Cancer From 2008

Recruiting
  • Metastatic Breast Cancer
    • Angers, France
    • +19 more
    Jun 30, 2022

    Other Cancer, Gastrointestinal Cancer, Thoracic Cancer Trial in United States (eSyM App Usage, SASS Questionnaire)

    Recruiting
    • Other Cancer
    • +3 more
    • eSyM App Usage
    • SASS Questionnaire
    • Portland, Maine
    • +5 more
    Nov 2, 2021

    Prostate Cancer, Bone Metastases Trial in Brescia (Zoledronic Acid, Enzalutamide)

    Recruiting
    • Prostate Cancer
    • Bone Metastases
    • Brescia, Italy
      Azienda Ospedaliera Spedali Civili di Brescia
    Mar 4, 2022

    Acute Myelocytic Leukemia, Myelodysplastic Syndrome Trial in Germany (Azacitidine)

    Completed
    • Acute Myelocytic Leukemia
    • Myelodysplastic Syndrome
    • Berlin, Germany
    • +10 more
    Nov 12, 2021

    Breast Cancer, Tumor Metastasis Trial in Houston (Trastuzumab, RAD001)

    Completed
    • Breast Cancer
    • Neoplasm Metastasis
    • Houston, Texas
      UT MD Anderson Cancer Center
    Sep 30, 2022

    Metastatic Triple Negative Breast Cancer to Immunotherapy Based

    Suspended
    • Metastatic Triple-Negative Breast Cancer
      • El Paso, Texas
        Texas Tech University HSC El Paso
      May 17, 2021

      Autonomic Nervous System in Patients Undergoing Esophagectomy

      Not yet recruiting
      • Esophageal Cancer
      • Holter ECG
      • +2 more
      • Saint-Étienne, France
        Centre Hospitalier Universitaire de Saint-Etienne
      Dec 1, 2021

      Medication Adherence Trial in Greenville (Nurse Coach Intervention)

      Completed
      • Medication Adherence
      • Nurse Coach Intervention
      • Greenville, North Carolina
        Vidant Medical Center
      Jul 20, 2021

      Breast Cancer Trial in Mexico (ePRO application and proactive clinical care with nurses.)

      Not yet recruiting
      • Breast Cancer
      • ePRO application and proactive clinical care with nurses.
      • Mexico, Ciudad De México, Mexico
        Hospital de Oncología del Centro Médico Nacional Siglo XXI
      Jun 28, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Toronto (MET-4)

      Active, not recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jan 8, 2023

      Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,

      Not yet recruiting
      • Advanced Uveal Melanoma
      • +2 more
      • BRD4 Inhibitor PLX2853
      • +4 more
      • (no location specified)
      Jan 9, 2023

      Sarcoma Trial in Shanghai (Apatinib monotherapy)

      Recruiting
      • Sarcoma
      • Apatinib monotherapy
      • Shanghai, Shanghai, China
        Ruijin Hospital Shanghai Jiao Tong University School of Medicine
      May 18, 2022

      Neuroblastoma, Pheochromocytoma Trial in New Hyde Park (131-I-meta-iodobenzylguanidine)

      Available
      • Neuroblastoma
      • Pheochromocytoma
      • New Hyde Park, New York
        Cohen Children's Medical Center
      Apr 4, 2022

      Cancer, Pregnancy Trial in Leuven

      Recruiting
      • Cancer
      • Pregnancy
        • Leuven, Belgium
          University Hospitals Leuven
        May 4, 2021

        NSCLC Trial in Guangzhou (anti-PD1 antibody-activated TILs)

        Unknown status
        • Non-small Cell Lung Cancer
        • anti-PD1 antibody-activated TILs
        • Guangzhou, Guangdong, China
          Sun Yat-Sen University, Cancer Center
        Apr 3, 2019

        Rectal Cancer, Self Efficacy Trial in Boston (PATHWAYS, Enhanced usual care)

        Not yet recruiting
        • Rectal Cancer
        • Self Efficacy
        • PATHWAYS
        • Enhanced usual care
        • Boston, Massachusetts
          Massachusetts General Hospital
        Jun 22, 2023

        Metastatic Pancreatic Cancer Trial in Dallas (SGT-53, nab-paclitaxel, Gemcitabine)

        Recruiting
        • Metastatic Pancreatic Cancer
        • SGT-53
        • +2 more
        • Dallas, Texas
          Mary Crowley Cancer Research Center
        Feb 7, 2022

        Breast Cancer Trial in Baltimore (Tamoxifen Citrate, Letrozole, Exemestane)

        Recruiting
        • Breast Cancer
        • Tamoxifen Citrate
        • +4 more
        • Baltimore, Maryland
          Johns Hopkins Bayview Hospital
        Nov 30, 2021

        Breast Cancer, Peripheral Neuropathy Trial (Placebo, NBP Softgel Capsules)

        Not yet recruiting
        • Breast Cancer
        • Peripheral Neuropathy
        • Placebo
        • NBP Softgel Capsules
        • (no location specified)
        Oct 12, 2022

        Stage IV Colorectal Cancer Trial in Netherlands (Nutritional counseling)

        Completed
        • Stage IV Colorectal Cancer
        • Nutritional counseling
        • Amsterdam, Netherlands
        • +4 more
        Dec 20, 2018

        Glioblastoma Trial in Rochester (WSD0628)

        Not yet recruiting
        • Glioblastoma
        • Rochester, Minnesota
          Mayo Clinic
        Jun 15, 2023

        Child Solid Tumor Trial in Seattle (biological, drug, procedure)

        Terminated
        • Unspecified Childhood Solid Tumor, Protocol Specific
        • filgrastim
        • +6 more
        • Seattle, Washington
        • +1 more
        Apr 3, 2019

        Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

        Recruiting
        • Non-muscle-invasive Bladder Cancer
        • Cairo, Egypt
          Mohamed Fawzy Salman
        Nov 19, 2022

        Advanced Solid Tumors Trial in Shanghai (CSPCHA131)

        Unknown status
        • Advanced Solid Tumors
        • Shanghai, China
          Fudan University Shanghai Cancer Center
        Jan 4, 2021